Innoviva, Inc.
DE ˙ DB ˙ US45781M1018
19,20 € ↑0,70 (3,78%)
2026-06-04
DEL PRIS
SecurityDE:HVE / Innoviva, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership2,279,451 shares
Latest Disclosed Value $ 53,111,208
Millennium Management Llc ownership in HVE / Innoviva, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 2,279,451 shares of Innoviva, Inc. (DE:HVE) valued at $45,589,020 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,610,305 shares of Innoviva, Inc.. This represents a change in shares of 41.55% during the quarter. The current value of the position is $43,765,459 USD.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (HVE) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:HVE / Innoviva, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INNOVIVA COM 45781M101 2,279,451 669,146 41.55 53,111 65.00 0.0221
2026-02-17 2025-12-31 13F INNOVIVA COM 45781M101 1,610,305 -31,010 -1.89 32,190 7.47 0.0135
2025-11-14 2025-09-30 13F INNOVIVA COM 45781M101 1,641,315 -348,037 -17.49 29,954 -25.05 0.0128
2025-08-14 2025-06-30 13F INNOVIVA COM 45781M101 1,989,352 313,295 18.69 39,966 31.53 0.0193
2025-05-15 2025-03-31 13F INNOVIVA COM 45781M101 1,676,057 1,275,444 318.37 30,387 337.21 0.0162
2025-02-14 2024-12-31 13F INNOVIVA COM 45781M101 400,613 324,515 426.44 6,951 373.11 0.0034
2024-11-14 2024-09-30 13F INNOVIVA COM 45781M101 76,098 53,415 235.48 1,469 294.89 0.0007
2024-08-14 2024-06-30 13F INNOVIVA COM 45781M101 22,683 4,992 28.22 372 38.29 0.0002
2024-05-15 2024-03-31 13F INNOVIVA COM 45781M101 17,691 17,691 270 0.0001
2024-02-14 2023-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 0 -1,717,862 -100.00 0 -100.00
2023-11-14 2023-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 1,717,862 1,588,867 1,231.73 4,621 284.12 0.0023
2023-11-14 2023-09-30 13F INNOVIVA COM 45781M101 375,136 -657,469 4,873 0.0025
2023-08-14 2023-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 128,995 48,960 61.17 1,204 69.20 0.0006
2023-08-14 2023-06-30 13F INNOVIVA COM 45781M101 1,032,605 -73,207 13,145 0.0065
2023-05-15 2023-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 80,035 -2,054,121 -96.25 711 -97.49 0.0004
2023-05-15 2023-03-31 13F INNOVIVA COM 45781M101 1,105,812 -1,028,344 12,440 0.0071
2023-02-14 2022-12-31 13F INNOVIVA COM 45781M101 2,134,156 -369,816 -14.77 28,278 -2.73 0.0156
2022-11-14 2022-09-30 13F INNOVIVA COM 45781M101 2,503,972 1,178,325 88.89 29,071 48.57 0.0172
2022-08-15 2022-06-30 13F INNOVIVA COM 45781M101 1,325,647 149,102 12.67 19,567 -14.05 0.0121
2022-05-16 2022-03-31 13F INNOVIVA COM 45781M101 1,176,545 -75,877 -6.06 22,766 5.38 0.0121
2022-02-14 2021-12-31 13F INNOVIVA COM 45781M101 1,252,422 -44,688 -3.45 21,604 -0.33 0.0110
2021-11-15 2021-09-30 13F INNOVIVA COM 45781M101 1,297,110 599,655 85.98 21,675 131.74 0.0130
2021-08-16 2021-06-30 13F INNOVIVA COM 45781M101 697,455 683,575 4,924.89 9,353 5,534.34 0.0057
2021-05-17 2021-03-31 13F INNOVIVA COM 45781M101 13,880 13,880 166 0.0001
2021-02-16 2020-12-31 13F INNOVIVA COM 45781M101 0 -71,438 -100.00 0 -100.00
2020-11-16 2020-09-30 13F INNOVIVA COM 45781M101 71,438 71,438 747 0.0009
2020-02-14 2019-12-31 13F INNOVIVA COM 45781M101 0 -422,266 -100.00 0 -100.00
2019-11-14 2019-09-30 13F INNOVIVA COM 45781M101 422,266 399,551 1,758.97 4,450 1,244.41 0.0070
2019-08-15 2019-06-30 13F/A-1 INNOVIVA COM 45781M101 22,715 22,715 331 0.0005
2019-05-14 2019-03-31 13F INNOVIVA COM 45781M101 0 -324,698 -100.00 0 -100.00
2019-02-15 2018-12-31 13F/A-1 INNOVIVA COM 45781M101 324,698 234,439 259.74 5,666 311.77 0.0088
2019-02-14 2018-12-31 13F INNOVIVA COM 45781M101 324,698 5,666
2018-11-14 2018-09-30 13F INNOVIVA COM 45781M101 90,259 -122,924 -57.66 1,376 -53.23 0.0017
2018-08-14 2018-06-30 13F INNOVIVA COM 45781M101 213,183 -125,827 -37.12 2,942 -47.94 0.0038
2018-05-15 2018-03-31 13F INNOVIVA COM 45781M101 339,010 278,287 458.29 5,651 555.57 0.0075
2018-02-14 2017-12-31 13F INNOVIVA COM 45781M101 60,723 -623,048 -91.12 862 -91.07 0.0012
2017-11-14 2017-09-30 13F INNOVIVA COM 45781M101 683,771 683,771 9,655 0.0147
2017-02-14 2016-12-31 13F INNOVIVA COM 45781M101 0 -468,921 -100.00 0 -100.00
2016-11-14 2016-09-30 13F INNOVIVA COM 45781M101 468,921 -106,402 -18.49 5,153 -14.94 0.0086
2016-08-15 2016-06-30 13F INNOVIVA COM 45781M101 575,323 -802,677 -58.25 6,058 -65.08 0.0139
2016-05-16 2016-03-31 13F INNOVIVA COM 45781M101 1,378,000 1,112,174 418.38 17,349 519.16 0.0434
2016-02-16 2015-12-31 13F THERAVANCE COM 88338T104 265,826 -562,400 -67.90 2,802 -52.88 0.0059
2015-11-16 2015-09-30 13F THERAVANCE COM 88338T104 828,226 691,047 503.76 5,947 139.90 0.0115
2015-08-14 2015-06-30 13F THERAVANCE COM 88338T104 137,179 137,179 0.00 2,479 0.0047
2015-05-15 2015-03-31 13F THERAVANCE COM 88338T104 0 -86,605 -100.00 0 -100.00
2015-02-17 2014-12-31 13F THERAVANCE COM 88338T104 86,605 60,402 230.52 1,225 173.44 0.0026
2014-11-14 2014-09-30 13F THERAVANCE COM 88338T104 26,203 -312,710 -92.27 448 -96.29 0.0011
2014-02-14 2013-12-31 13F THERAVANCE COM 88338T104 338,913 27,635 8.88 12,082 -5.03 0.0381
2013-11-14 2013-09-30 13F THERAVANCE COM 88338T104 311,278 261,278 522.56 12,722 560.20 0.0410
2013-08-14 2013-06-30 13F THERAVANCE COM 88338T104 50,000 50,000 1,927 0.0059
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-02-14 2021-12-31 13F INNOVIVA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F INNOVIVA COM Call 200,000 -33.33 3,342 -16.93 n/a n/a n/a
2021-08-16 2021-06-30 13F INNOVIVA COM Call 300,000 8.88 4,023 -8.53 n/a n/a n/a
2019-08-14 2019-06-30 13F HERTZ GLOBAL HLDGS RIGHT 07/12/2019 Call 275,544 4,398 n/a n/a n/a
2014-11-14 2014-09-30 13F THERAVANCE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-08-14 2014-06-30 13F THERAVANCE COM Call 136,700 63.52 4,071 19.14 n/a n/a n/a
2014-02-14 2013-12-31 13F THERAVANCE COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2013-11-14 2013-09-30 13F THERAVANCE COM Call 83,600 3,417 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-05-15 2014-03-31 13F THERAVANCE COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2014-02-14 2013-12-31 13F THERAVANCE COM Put 140,200 4,998 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.